Antiplatelet agents and anaesthesia
نویسندگان
چکیده
منابع مشابه
Antiplatelet agents and anaesthesia
Antiplatelet agents are increasingly being used in the management of all types of atherosclerotic disease, and, accordingly, patients on them are presenting more frequently for anaesthesia. Presentations range from elective patients taking aspirin as monotherapy for primary prevention of cardiovascular morbidity, to those maintained on multiple therapies requiring salvage surgery after a cardio...
متن کاملAntiplatelet agents and heart
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706–17. [12] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (Caprie). Caprie steering committee. Lancet 1996;348: 1329–39. [13] Di Dedda U, Ranucci M, Baryshnikova E, Castelvecchio S. Thienopyridines resistance and recovery of pla...
متن کاملThrombolytics, anticoagulants, and antiplatelet agents.
Thrombolytics The key publication on thrombolytic therapy in acute ischemic stroke using recombinant tissue plasminogen activator was published almost 10 years ago, which led to the approval of this drug in many countries.1 Since then, considerable knowledge has been gained about the risks and benefits of thrombolytic therapy. However, 1 major concern is still the limited time window of 3 hours...
متن کاملAntiplatelet agents and perioperative bleeding.
PURPOSE To briefly review the risks, in patients presenting for surgery, associated with the available antiplatelet agents, and to present the principles that should guide the evaluation of these risks and how to manage them. METHODS A narrative review of the current medical literature in English and French. MAIN FINDINGS Antiplatelet agents [mainly acetylsalicylic acid, clopidogrel and gly...
متن کاملPerioperative management of antiplatelet agents.
Perioperative management of antiplatelet agents is a common challenge with the increased number of patients requiring long-term therapy following coronary stenting. Debate currently exists regarding if and when to discontinue antiplatelet therapy prior to elective surgery. The delicate balance between decreasing the risk of bleeding intraoperatively and minimizing the risk of stent thrombosis i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Continuing Education in Anaesthesia Critical Care & Pain
سال: 2007
ISSN: 1743-1816
DOI: 10.1093/bjaceaccp/mkm030